DEA schedule
Is Wegovy a controlled substance?
Wegovy contains semaglutide. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Wegovy (semaglutide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and semaglutide is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Wegovy?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 12 prescription listings from 2 labelers, none with a DEA schedule |
| DEA controlled substances list | semaglutide is not on the list |
Wegovy NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0169-4525 | WEGOVY | injection, solution | .25 mg/.5mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 50090-5824 | WEGOVY | injection, solution | .25 mg/.5mL | A-S Medication Solutions | None |
| 0169-4505 | WEGOVY | injection, solution | .5 mg/.5mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4501 | WEGOVY | injection, solution | 1 mg/.5mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4517 | WEGOVY | injection, solution | 1.7 mg/.75mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4524 | WEGOVY | injection, solution | 2.4 mg/.75mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4915 | WEGOVY | injection, solution | 3.2 mg/mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4572 | WEGOVY | injection, solution | 7.2 mg/.75mL | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4415 | WEGOVY | tablet | 1.5 mg/1 | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4425 | WEGOVY | tablet | 25 mg/1 | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4404 | WEGOVY | tablet | 4 mg/1 | Novo Nordisk Pharmaceutical Industries, LP | None |
| 0169-4409 | WEGOVY | tablet | 9 mg/1 | Novo Nordisk Pharmaceutical Industries, LP | None |
Questions
Is Wegovy a controlled substance?
No. Wegovy (semaglutide) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and semaglutide is not on the DEA controlled substances list.
Is Wegovy a narcotic?
No. Wegovy (semaglutide) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is GLP-1 Receptor Agonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Wegovy
- What is Wegovy used for?FDA label uses
- Generic for WegovyFDA Orange Book
- Generic for OzempicFDA Orange Book
- Generic for Wegovy FlextouchFDA Orange Book
- Generic for Wegovy HdFDA Orange Book
- Generic for RybelsusFDA Orange Book
- GLP-1 Receptor Agonists listFDA drug class
- Wegovy Medicare Part D coverageBy plan and state
- NDC 0169-4404Wegovy NDC record
- NDC 0169-4409Wegovy NDC record
- NDC 0169-4415Wegovy NDC record